Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Director Amy Mcbride Wendell purchased 16,264 shares of the business’s stock in a transaction on Thursday, September 14th. The shares were bought at an average price of $1.23 per share, for a total transaction of $20,004.72. Following the purchase, the director now directly owns 16,264 shares in the company, valued at approximately $20,004.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Ekso Bionics Holdings, Inc. (NASDAQ EKSO) traded down 6.50% during mid-day trading on Friday, hitting $1.15. 613,937 shares of the stock traded hands. The company has a 50 day moving average of $1.47 and a 200-day moving average of $2.19. The stock’s market cap is $29.66 million. Ekso Bionics Holdings, Inc. has a 12-month low of $0.99 and a 12-month high of $6.38.

TRADEMARK VIOLATION WARNING: This piece was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.thecerbatgem.com/2017/09/17/amy-mcbride-wendell-acquires-16264-shares-of-ekso-bionics-holdings-inc-ekso-stock.html.

Separately, Zacks Investment Research lowered shares of Ekso Bionics Holdings from a “buy” rating to a “hold” rating in a research note on Wednesday.

Institutional investors have recently made changes to their positions in the company. Independence Advisors LLC acquired a new position in shares of Ekso Bionics Holdings in the 2nd quarter valued at $1,840,000. Carl Domino Inc increased its holdings in shares of Ekso Bionics Holdings by 74.7% in the 2nd quarter. Carl Domino Inc now owns 82,054 shares of the company’s stock valued at $190,000 after acquiring an additional 35,088 shares during the period. Intellectus Partners LLC increased its holdings in shares of Ekso Bionics Holdings by 5.3% in the 2nd quarter. Intellectus Partners LLC now owns 105,294 shares of the company’s stock valued at $244,000 after acquiring an additional 5,294 shares during the period. National Planning Corp increased its holdings in shares of Ekso Bionics Holdings by 116.2% in the 2nd quarter. National Planning Corp now owns 234,450 shares of the company’s stock valued at $537,000 after acquiring an additional 126,000 shares during the period. Finally, Vanguard Group Inc. increased its holdings in shares of Ekso Bionics Holdings by 32.9% in the 2nd quarter. Vanguard Group Inc. now owns 711,082 shares of the company’s stock valued at $1,650,000 after acquiring an additional 176,197 shares during the period. 6.04% of the stock is currently owned by institutional investors and hedge funds.

About Ekso Bionics Holdings

Ekso Bionics Holdings, Inc designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness.

Receive News & Stock Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related stocks with our FREE daily email newsletter.